Imipenem resistance in Salmonella enterica serovar Wien related to porin loss and CMY-4 β-lactamase production

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 3, 2003, Pages 1165-1168

  Armand Lefevre L ^a,b   Leflon Guibout, V ^a,b   Bredin, J ^c   Barguellil, F ^d   Amor, A ^d   Pages J M ^c   Nicolas Chanoine, M H ^a,b  

^a HÔPITAL AMBROISE PARÉ   (France)

^b LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^c AIX MARSEILLE UNIVERSITY   (France)

^d MILITARY HOSPITAL OF TUNIS   (Tunisia)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAMASE; BETA LACTAMASE TEM 1; CEFALOTIN; CEFEPIME; CEFEPIME PLUS CLAVULANIC ACID; CEFOTAXIME; CEFOTAXIME PLUS CLAVULANIC ACID; CEFOTETAN; CEFOXITIN; CEFPIROME; CEFTAZIDIME; CEFTAZIDIME PLUS CLAVULANIC ACID; CIPROFLOXACIN; CLAVULANIC ACID; CMY 4 BETA LACTAMASE; CTX M3 BETA LACTAMASE; IMIPENEM; NALIDIXIC ACID; NORFLOXACIN; OUTER MEMBRANE PROTEIN; OUTER MEMBRANE PROTEIN F; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; PORIN; SHV 2A BETA LACTAMASE; TICARCILLIN; TIMENTIN; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL MUTATION; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG MIXTURE; ENZYME SYNTHESIS; ESCHERICHIA COLI; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SALMONELLA ENTERICA;

4-QUINOLONES; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; BACTERIAL OUTER MEMBRANE PROTEINS; BETA-LACTAMASES; DNA PRIMERS; DRUG RESISTANCE, BACTERIAL; HUMANS; IMIPENEM; INFANT, NEWBORN; PLASMIDS; PORINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SALMONELLA ENTERICA; THIENAMYCINS; TRANSFORMATION, BACTERIAL;

EID: 0037417007     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.3.1165-1168.2003     Document Type: Article

References (20)

1. Archambaud, M., G. Gerbaud, E. Labau, N. Marty, and P. Courvalin. 1991. Possible in vivo transfer of beta-lactamase TEM-3 from Klebsiella pneumoniae to Salmonella kedougou. J. Antimicrob. Chemother. 27:427-436.
2. PER-2, which encodes an extended-spectrum class A betalactamase. Antimicrob. Agents Chemother. 40:616-620.
3. Bradford, P. A., C. Urban, N. Mariano, S. J. Projan, J. J. Rahal, and K. Bush. 1997. Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the loss of an outer membrane protein. Antimicrob. Agents Chemother. 41:563-569.
4. Bradford, P. A., Y. Yang, D. Sahm, I. Grope, D. Gardovska, and G. Storch. 1998. CTX-M-5, a novel cefotaxime-hydrolyzing beta-lactamase from an outbreak of Salmonella typhimurium in Latvia. Antimicrob. Agents Chemother. 42:1980-1984.
5. Cowan, S. W., T. Schirmer, G. Rummel, M. Steiert, R. Ghosh, R. A. Pauptit, J. N. Jansonius, and J. P. Rosenbusch. 1992. Crystal structures explain functional properties of two E. coli porins. Nature 358:727-733.
6. De, E., A. Basle, M. Jaquinod, N. Saint, M. Mallea, G. Molle, and J. M. Pages. 2001. A new mechanism of antibiotic resistance in Enterobacteriaceae induced by a structural modification of the major porin. Mol. Microbiol. 41:189-198.
7. Dunne, E. F., P. D. Fey, P. Kludt, R. Reporter, F. Mostashari, P. Shillam, J. Wicklund, C. Miller, B. Holland, K. Stamey, T. J. Barrett, J. K. Rasheed, F. C. Tenover, E. M. Ribot, and F. J. Angulo. 2000. Emergence of domestically acquired ceftriaxone-resistant Salmonella infections associated with AmpC beta-lactamase. JAMA 284:3151-3156.
8. Gaillot, O., C. Clement, M. Simonet, and A. Philippon. 1997. Novel transferable beta-lactam resistance with cephalosporinase characteristics in Salmonella enteritidis. J. Antimicrob. Chemother. 39:85-87.
9. Hammami, A., G. Arlet, S. Ben Redjeb, F. Grimont, A. Ben Hassen, A. Rekik, and A. Philippon. 1991. Nosocomial outbreak of acute gastroenteritis in a neonatal intensive care unit in Tunisia caused by multiply drug resistant Salmonella wien producing SHV-2 beta-lactamase. Eur. J. Clin. Microbiol. Infect. Dis. 10:641-646.
10. Karshikoff, A., V. Spassov, S. W. Cowan, R. Ladenstein, and T. Schirmer. 1994. Electrostatic properties of two porin channels from Escherichia coli. J. Mol. Biol. 240:372-384.
11. Mallea, M., J. Chevalier, C. Bornet, A. Eyraud, A. Davin-Regli, C. Bollet, and J. M. Pages. 1998. Porin alteration and active efflux: two in vivo drug resistance strategies used by Enterobacter aerogenes. Microbiology 144:3003-3009.
12. Mariotte, S., P. Nordmann, and M. H. Nicolas. 1994. Extended-spectrum beta-lactamase in Proteus mirabilis. J. Antimicrob. Chemother. 33:925-935.
13. Navarro, F., E. Perez-Trallero, J. M. Marimon, R. Aliaga, M. Gomariz, and B. Mirelis. 2001. CMY-2-producing Salmonella enterica, Klebsiella pneumoniae, Klebsiella oxytoca, Proteus mirabilis and Escherichia coli strains isolated in Spain (October 1999-December 2000). J. Antimicrob. Chemother. 48:383-389.
14. Rasheed, J. K., C. Jay, B. Metchock, F. Berkowitz, L. Weigel, J. Crellin, C. Steward, B. Hill, A. A. Medeiros, and F. C. Tenover. 1997. Evolution of extended-spectrum beta-lactam resistance (SHV-8) in a strain of Escherichia coli during multiple episodes of bacteremia. Antimicrob. Agents Chemother. 41:647-653.
15. Simarro, E., F. Navarro, J. Ruiz, E. Miro, J. Gomez, and B. Mirelis. 2000. Salmonella enterica serovar Virchow with CTX-M-like beta-lactamase in Spain. J. Clin. Microbiol. 38:4676-4678.
16. Simonet, V., M. Mallea, D. Fourel, J. M. Bolla, and J. M. Pages. 1996. Crucial domains are conserved in Enterobacteriaceae porins. FEMS Microbiol. Lett. 136:91-97.
17. Simonet, V., M. Mallea, and J. M. Pages. 2000. Substitutions in the eyelet region disrupt cefepime diffusion through the Escherichia coli OmpF channel. Antimicrob. Agents Chemother. 44:311-315.
18. Speldooren, V., B. Heym, R. Labia, and M.-H. Nicolas-Chanoine. 1998. Discriminatory detection of inhibitor-resistant beta-lactamases in Escherichia coli by single strand conformational polymorphism-PCR. Antimicrob. Agents Chemother. 42:879-884.
19. Stapleton, P. D., K. P. Shannon, and G. L. French. 1999. Carbapenem resistance in Escherichia coli associated with plasmid-determined CMY-4 beta-lactamase production and loss of an outer membrane protein. Antimicrob. Agents Chemother. 43:1206-1210.
20. Verdet, C., G. Arlet, S. Ben Redjeb, A. Ben Hassen, P. H. Lagrange, and A. Philippon. 1998. Characterisation of CMY-4, an AmpC-type plasmid-mediated beta-lactamase in a Tunisian clinical isolate of Proteus mirabilis. FEMS Microbiol. Lett. 169:235-240.